Xinyan Pan

212 Daguan Rd
Kunming, 650032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Single-cell mapping of extrachromosomal circular DNA architecture and evolution in cutaneous squamous cell carcinoma.

Single-cell mapping of extrachromosomal circular DNA architecture and evolution in cutaneous squamous cell carcinoma.

Journal: Cancer letters

Published: February 15, 2026

KRAS mutations promote PD-L1-mediated immune escape by ETV4 in lung adenocarcinoma.

KRAS mutations promote PD-L1-mediated immune escape by ETV4 in lung adenocarcinoma.

Journal: Translational oncology

Published: March 30, 2025

Comprehensive multi-omics analysis of tandem duplicator phenotypes in non-small cell lung cancer.

Comprehensive multi-omics analysis of tandem duplicator phenotypes in non-small cell lung cancer.

Journal: Frontiers in medicine

Published: January 10, 2025

IgG4-mediated M2 macrophage polarization in tertiary lymphoid structures of esophageal cancer: implications for immunosuppression.

IgG4-mediated M2 macrophage polarization in tertiary lymphoid structures of esophageal cancer: implications for immunosuppression.

Journal: Frontiers in immunology

Published: September 17, 2024

KRAS mutation promotes immune escape of lung adenocarcinoma via ZNF24/SLC7A5/PD-L1 axis.

KRAS mutation promotes immune escape of lung adenocarcinoma via ZNF24/SLC7A5/PD-L1 axis.

Journal: BMC cancer

Published: September 08, 2024

ZNF24 regulates the progression of KRAS mutant lung adenocarcinoma by promoting SLC7A5 translation.

ZNF24 regulates the progression of KRAS mutant lung adenocarcinoma by promoting SLC7A5 translation.

Journal: Frontiers in oncology

Published: September 13, 2022

RNA Interference Induces BRCA1 Gene Methylation and Increases the Radiosensitivity of Breast Cancer Cells.

RNA Interference Induces BRCA1 Gene Methylation and Increases the Radiosensitivity of Breast Cancer Cells.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: February 18, 2022

BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor.

BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor.

Journal: PloS one

Published: December 27, 2021

Inhibition of human lung cancer cells by anti-p21Ras scFv mediated by the activatable cell-penetrating peptide.

Inhibition of human lung cancer cells by anti-p21Ras scFv mediated by the activatable cell-penetrating peptide.

Journal: Anti-cancer drugs

Published: August 02, 2021

The immunoreactivity of the anti-p21Ras single-chain fragment variant KGH-R1 and its predicted binding sites to p21Ras.

The immunoreactivity of the anti-p21Ras single-chain fragment variant KGH-R1 and its predicted binding sites to p21Ras.

Journal: Immunotherapy

Published: July 16, 2020

Recombinant Adenovirus KGHV500 and CIK Cells Codeliver Anti-p21-Ras scFv for the Treatment of Gastric Cancer with Wild-Type Ras Overexpression.

Recombinant Adenovirus KGHV500 and CIK Cells Codeliver Anti-p21-Ras scFv for the Treatment of Gastric Cancer with Wild-Type Ras Overexpression.

Journal: Molecular therapy oncolytics

Published: July 12, 2018

5-aza-2'-Deoxycytidine enhances the radiosensitivity of breast cancer cells.

5-aza-2'-Deoxycytidine enhances the radiosensitivity of breast cancer cells.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: August 25, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026